US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

118.55

+1.951.67%

Volume:7K

Turnover:797.37K

Market Cap:103.14M

PE:- -

High:118.55

Open:115.47

Low:115.47

Close:116.60

52wk High:126.40

52wk Low:55.34

Shares:870.00K

Float Shares:870.00K

Volume Ratio:0.69

T/O Rate:0.78%

Dividend:0.33

Dividend Rate:0.27%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results

Crinetics Faces Shareholder Challenges to Vertex Merger Deal

Moderna Inc. Stock Rallies 177.0%, Outperforms Peers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/BIB/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":118.5483,"timestamp":1788292800000,"preClose":116.5968,"halted":0,"volume":6774,"delay":0,"changeRate":0.016737166028570217,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"Pre-Mkt","change":1.9515,"latestTime":"09-02 04:36:45 EDT","open":115.47,"high":118.5483,"low":115.47,"amount":797373.43338,"amplitude":0.026401,"askPrice":122.38,"askSize":122,"bidPrice":114.99,"bidSize":130,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":118.5483,"sharesOutstanding":1040000,"nav":116.4962,"aum":101351694,"dividendRate":0.002749,"bidAskSpread":0.002656,"postHourTrading":{"tag":"盘后","latestPrice":118.41,"preClose":118.5483,"latestTime":"19:30 EDT","volume":63,"amount":7463.0398,"timestamp":1788305406177,"change":-0.1383,"changeRate":-0.001167,"amplitude":0},"volumeRatio":0.6933327839075312,"impliedVol":0.4703,"impliedVolPercentile":0.6733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6933327839075312,"shares":870000,"dividePrice":0.3259,"high":118.5483,"amplitude":0.026401,"preClose":116.5968,"low":115.47,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":118.5483,"committee":0.031746,"eps":0,"divideRate":0.002749,"volume":6774,"delay":0,"ttmEps":0,"open":115.47,"prevYearClose":79.7794,"prevWeekClose":116.3898,"prevMonthClose":116.5968,"prevQuarterClose":100.74,"fiveDayClose":125.1901,"twentyDayClose":100.17,"sixtyDayClose":80.2719},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","BK4566","LU0965509283.SGD","LU1430594728.SGD","LU0109394709.USD","BIB","LU1037948897.HKD","LU0320765992.SGD","LU2357627491.SGD","BMED","LU0114720955.EUR","LU1061106388.HKD","LU1934455194.USD","TMED","LU1934455863.HKD","BBH","LU0289739699.SGD","IBBQ","LU0823416689.USD","MEDI","LU1037948541.HKD","LU0965509010.AUD","LU1057294990.SGD","LU2089984988.USD","LU1778281490.HKD","LU0965508806.USD","BK4583","BK4585","SG9999015952.SGD","IE00B3T34201.USD","LU1674673691.USD","LU0965509101.SGD","TBXU","LU1066051498.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0859254822.USD","LU0861579265.USD","LU1934455277.USD","LU0058720904.USD","SG9999015978.USD","IE0002270589.USD","LU1023059063.AUD","LU0882574055.USD","SG9999015986.USD","IBB","LU1585245621.USD","BK4550","LU2468319806.SGD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325278","title":"Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IBBQ","LU1023059063.AUD","BK4550","LU0234570918.USD","BBH","BK4585","BIB","SG9999015945.SGD","SG9999015986.USD","LU1066053197.SGD","IE00B3T34201.USD","BK4568","LU1934455863.HKD","IE00BSNM7G36.USD","LU2468319806.SGD","SG9999015952.SGD","LU1674673428.USD","LU1934455277.USD","BK4588","LU0965508806.USD","IE00BZ1G4Q59.USD","SG9999015978.USD","LU0889565916.HKD","GILD","LU0965509283.SGD","LU1057294990.SGD","LU1585245621.USD","LU1674673691.USD","MEDI","LU1037948897.HKD","LU0320765992.SGD","LU0965509101.SGD","LU1066051498.USD","IE0002270589.USD","IE00B7SZLL34.SGD","TMED","IBB","BK4566","LU0965509010.AUD","LU0289739699.SGD","LU0058720904.USD","TBXU","LU2324357040.USD","BMED","IE00B19Z3B42.SGD","LU1934455194.USD","LU2357627491.SGD","LU1839511570.USD","LU1061106388.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278323","title":"European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278323?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","LU0058720904.USD","BK4585","LU1585245621.USD","LU2089984988.USD","SG9999015978.USD","MEDI","BBH","IE00B19Z3B42.SGD","LU0320765992.SGD","IE00B7SZLL34.SGD","BIB","LU2087621335.USD","LU0109394709.USD","LU0965509101.SGD","SG9999015952.SGD","LU0234570918.USD","BK4532","LU0122379950.USD","LU0823416689.USD","BK4139","LU0861579265.USD","LU1674673691.USD","SG9999015945.SGD","TBXU","LU0859254822.USD","IBBQ","BK4583","LU1066053197.SGD","BMED","LU0289739699.SGD","IE00B19Z3581.USD","BK4566","SG9999015986.USD","TMED","LU2324357040.USD","LU0882574055.USD","GILD","LU2357627491.SGD","LU1057294990.SGD","IBB","LU1674673428.USD","LU0114720955.EUR","LU1061106388.HKD","LU1037948541.HKD","LU1037948897.HKD","IE00BKVL7J92.USD","BK4588","LU0889565916.HKD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4588","BK4566","IE00B4R5TH58.HKD","LU1061106388.HKD","BK4533","LU2089984988.USD","AMGN","IE00BJJMRZ35.SGD","LU2242646821.SGD","LU1983299246.USD","LU2468319806.SGD","SG9999001440.SGD","LU2112291526.USD","LU0320765992.SGD","LU1571399168.USD","IBBQ","LU0289739699.SGD","LU1057294990.SGD","IE00B2B36J28.USD","TBXU","BK4534","PBE","IE00BJT1NW94.SGD","LU2242652126.USD","LU0868494617.USD","BK4585","IBB","LU0889565916.HKD","BK4599","LU0058720904.USD","BK4581","PJP","LU0122379950.USD","BBH","IE0009355771.USD","LU1023059063.AUD","IE00BFTCPJ56.SGD","BIB","LU0109394709.USD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0109394709.USD","VRTX","IBBQ","LU2065171402.SGD","CHAT","SG9999013999.USD","LU0432979614.USD","LU0889565916.HKD","LU0417517546.SGD","VIAG","VTHR","LU0234570918.USD","LU1585245621.USD","LU1069344957.HKD","LU2417539215.USD","LU1559883803.SGD","BK4585","BK4588","LU2362540622.SGD","IE0002141913.USD","BIB","QTOC","TBXU","AIPO","IE00B19Z9Z06.USD","BK4023","LU1674673428.USD","LU2462157665.USD","LU2065171311.SGD","LU2089984988.USD","LU2236285917.USD","VERX","SG9999001176.SGD","LU0240877869.USD","BBH","IBB","IE00B2B36J28.USD","LU0061475181.USD","VIAV","AGIX","LU1093756325.SGD","PBE","IE00B4R5TH58.HKD","BK4567","GNMX","IDNA","LU0205194284.USD","ARTY","LU2065170008.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242652126.USD","LU0417517546.SGD","LU0053666078.USD","LU0882574055.USD","LU1778281490.HKD","IE0002270589.USD","BIB","LU1934455194.USD","GNMX","LU0256863811.USD","BK4532","LU0122379950.USD","LU2362540622.SGD","LU2462157665.USD","LU0823434583.USD","LU1430594728.SGD","SG9999001440.SGD","IE00B19Z9P08.USD","TMED","LU2242646821.SGD","LU0965508806.USD","LU1571399168.USD","IE00BZ9MQY76.HKD","LU2106854487.HKD","SG9999015978.USD","LU1839511570.USD","LU1023059063.AUD","BK4599","IE00BN0W2T93.GBP","LU0234570918.USD","LU0154245673.USD","LU2236285917.USD","BK4566","LU1037948897.HKD","LU0965509283.SGD","LU1974910355.USD","AMGN","LU0859254822.USD","LU1069344957.HKD","LU2324357040.USD","LU0109394709.USD","IE00B2B36J28.USD","LU0823434740.USD","IE00B3T34201.USD","LU1057294990.SGD","LU1934455277.USD","LU0079474960.USD","LU0861579265.USD","SG9999001176.USD","LU0965509010.AUD","LU2468319806.SGD","LU2362541513.USD","REGN","BBH","IE00BN0W2W23.USD","IE00BFTCPJ56.SGD","LU2112291526.USD","LU0114720955.EUR","LU0061475181.USD","LU1037948541.HKD","LU0320765992.SGD","MEDI","SG9999015986.USD","LU1066051498.USD","LU2023250504.SGD","IE00B19Z9Z06.USD","LU0058720904.USD","LU2417539215.USD","IBB","IE00B894F039.SGD","LU2087621335.USD","JAZZ","IE00B19Z3B42.SGD","LU1066053197.SGD","IE00BSNM7G36.USD","LU1035775433.USD","LU0868494617.USD","SG9999013999.USD","SG9999001176.SGD","IE0002141913.USD","IE0009355771.USD","LU1093756168.USD","VRTX","LU2362541273.HKD","IE00BJJMRZ35.SGD","LU1674673691.USD","LU1585245621.USD","SG9999015952.SGD","BMED","BK4583","IE00B7SZLL34.SGD","LU0432979614.USD","LU1061106388.HKD","BK4585","LU1674673428.USD","IE00B4R5TH58.HKD","BK4578","LU2357627491.SGD","TBXU","LU0889565916.HKD","BK4007","LU1093756325.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","BK4139","BK4568","LU2237438978.USD","IBBQ","PBE","IE00BN0W2V16.EUR","BK4581","BK4534","IDNA","LU0154245756.USD","PJP","XBI","SGXZ57979304.SGD","BK4588","SG9999015945.SGD","BK4533","LU2089984988.USD","LU0965509101.SGD","IE00BKVL7J92.USD","LU0823416689.USD","LU1934455863.HKD","04332","BK4550","BK4567","LU1983299246.USD","LU1917777945.USD","LU2456880835.USD","GILD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","BK4568","LU0058720904.USD","IBBQ","LU1674673691.USD","MEDI","LU0234570918.USD","LU2357627491.SGD","LU1585245621.USD","LU1430594728.SGD","SG9999015978.USD","IE00B19Z3581.USD","TBXU","BK4532","BK4583","IE00BSNM7G36.USD","LU0122379950.USD","LU1057294990.SGD","LU1674673428.USD","LU1778281490.HKD","TMED","IE00B3T34201.USD","LU0965509101.SGD","LU0320765992.SGD","LU0861579265.USD","BK4588","LU1571399168.USD","BK4566","LU0859254822.USD","IE00B19Z3B42.SGD","LU0882574055.USD","SG9999015945.SGD","LU0965509010.AUD","LU1023059063.AUD","BMED","LU0289739699.SGD","IE00B7SZLL34.SGD","SG9999015952.SGD","IBB","GILD","BIB","LU1934455863.HKD","BK4139","LU2089984988.USD","LU0965509283.SGD","SG9999015986.USD","LU0965508806.USD","LU1066053197.SGD","BBH","LU2087621335.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU2324357040.USD","LGHT","SG9999015952.SGD","LU0122379950.USD","BK4532","LU1585245621.USD","BK4501","IBB","IE0002270589.USD","LU1934455863.HKD","LU2357627491.SGD","MEDI","GNOM","LU0861579265.USD","IBBQ","LU0823416689.USD","WDNA","LU1037948541.HKD","SG9999015986.USD","LU1674673691.USD","MRNA","LU1839511570.USD","MRNY","SG9999015978.USD","MRNX","LU0058720904.USD","LU0234570918.USD","BK4551","LU0965508806.USD","BIB","GILD","IDNA","LU1061106388.HKD","TMED","LU0965509283.SGD","BK4583","LU1934455194.USD","LU0965509010.AUD","LU1430594728.SGD","BMED","LU0289739699.SGD","LU1571399168.USD","TBXU","BK4550","BK4585","LU1057294990.SGD","LU0320765992.SGD","LU2112291526.USD","LU1066053197.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0859254822.USD","LU0320765992.SGD","IE00B3T34201.USD","LU0823416689.USD","LU2357627491.SGD","IBBQ","LU2468319806.SGD","BK4568","BK4585","BK4583","BIB","LU0114720955.EUR","LU0965509283.SGD","TBXU","SG9999015952.SGD","LU0889565916.HKD","IE00BSNM7G36.USD","BBH","SG9999015986.USD","LU0122379950.USD","LU1430594728.SGD","LU2324357040.USD","BK4550","MEDI","LU1061106388.HKD","BK4588","IE00B7SZLL34.SGD","BK4578","LU1037948541.HKD","BMED","LU1037948897.HKD","IE00B19Z3B42.SGD","LU1023059063.AUD","IE0002270589.USD","IBB","LU0965509101.SGD","LU1674673428.USD","BK4532","LU0882574055.USD","LU1066053197.SGD","LU1585245621.USD","LU2089984988.USD","LU2112291526.USD","IE00BKVL7J92.USD","TMED","LU1674673691.USD","BK4139","LU0965509010.AUD","GILD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE0002141913.USD","LU1023059063.AUD","LU1571399168.USD","PBE","IE00B4R5TH58.HKD","LU2242652126.USD","BK4585","BK4581","PJP","IBB","LU2242646821.SGD","BK4534","BIB","LU2089984988.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","BK4599","LU1983299246.USD","LU0122379950.USD","BBH","IE00BJT1NW94.SGD","IBBQ","BK4566","LU0289739699.SGD","LU1061106388.HKD","TBXU","LU0868494617.USD","LU0320765992.SGD","LU2468319806.SGD","IE0009355771.USD","LU1057294990.SGD","AMGN","BK4588","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4139","LU2112291526.USD","BK4533","LU0058720904.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923014","title":"Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923014?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258134,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price.\n\nGilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BMED","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","LU1778281490.HKD","TSPA","LU1037948897.HKD","IE00B19Z3B42.SGD","IBB","SG9999015986.USD","LU0114720955.EUR","IE00BKVL7J92.USD","LU1430594728.SGD","BK4550","IE00BSNM7G36.USD","IBBQ","BIB","BK4588","IE0002270589.USD","LU0320765992.SGD","LU2087621335.USD","TMED","LU1934455194.USD","LU0965509283.SGD","LU2468319806.SGD","LU0823416689.USD","MEDI","LU0289739699.SGD","LU1934455863.HKD","LU0122379950.USD","DAPP","CDIG","BK4585","LU0965509010.AUD","TACU","LU1934455277.USD","GILD","LU2112291526.USD","BK4566","LU0861579265.USD","IE00BZ1G4Q59.USD","LU0965508806.USD","SG9999015978.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1066051498.USD","SG9999015945.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4550","LU0823416689.USD","LU1934455194.USD","LU2112291526.USD","LU2324357040.USD","BK4588","BK4139","IE00B3T34201.USD","LU0114720955.EUR","IE0002270589.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU0882574055.USD","LU0965509010.AUD","BMED","LU1057294990.SGD","LU1585245621.USD","MEDI","SG9999015986.USD","BK4568","BBH","LU1571399168.USD","LU1061106388.HKD","LU1674673691.USD","LU0289739699.SGD","LU0965508806.USD","BK4532","BK4578","LU0965509283.SGD","BK4566","LU0122379950.USD","LU1430594728.SGD","BK4583","LU2468319806.SGD","LU2087621335.USD","LU1037948897.HKD","IE00B19Z3581.USD","LU1037948541.HKD","LU0109394709.USD","LU1066053197.SGD","LU1934455277.USD","LU2089984988.USD","TBXU","SG9999015952.SGD","GILD","LU1674673428.USD","SG9999015945.SGD","BK4585","IE00BZ1G4Q59.USD","LU0861579265.USD","IE00B7SZLL34.SGD","LU0965509101.SGD","LU0320765992.SGD","SG9999015978.USD","LU1778281490.HKD","IBBQ","LU1839511570.USD","TMED","BIB","LU0058720904.USD","LU1934455863.HKD","LU0889565916.HKD","LU1023059063.AUD","IBB","LU1066051498.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232427","title":"Moderna Inc. Stock Slips 23.5%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232427?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7SZLL34.SGD","BK4533","BK4139","BK4550","BK4578","TMED","IBB","IDNA","IE00BSNM7G36.USD","LU1066053197.SGD","LU0965509010.AUD","MRNA","LU0058720904.USD","IBBQ","WDNA","LU1674673428.USD","BBH","BK4532","LU1430594728.SGD","BMED","SG9999015945.SGD","LU1934455194.USD","LU2468319806.SGD","LU2112291526.USD","LU1585245621.USD","BK4551","BK4566","LU0114720955.EUR","LU1778281490.HKD","BIB","MRNX","IE00B19Z3B42.SGD","LU2324357040.USD","LU1037948541.HKD","TBXU","LGHT","MEDI","LU0289739699.SGD","BK4548","LU1839511570.USD","LU0823416689.USD","LU1023059063.AUD","SG9999015952.SGD","GILD","LU0882574055.USD","LU0109394709.USD","MRNY","GNOM","LU1674673691.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["VERX","LU2362541513.USD","LU1674673428.USD","LU2362540622.SGD","BK4567","IBBQ","BK4588","IE00B19Z9P08.USD","SG9999001176.USD","LU0757428866.USD","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","SGXZ57979304.SGD","LU0889565916.HKD","IE00B2B36J28.USD","IDNA","IE00B19Z3581.USD","LU2324357040.USD","SG9999013999.USD","LU0566484027.USD","TBXU","VRTX","BK4139","LU2362541273.HKD","PBE","LU1093756325.SGD","LU1815336091.USD","LU0234570918.USD","LU2417539215.USD","LU1093756168.USD","IE0002141913.USD","LU2468319806.SGD","BK4585","LU1069344957.HKD","LU2456880835.USD","LU1674673691.USD","LU0289739699.SGD","LU0256863811.USD","LU0079474960.USD","BIB","IE00BFTCPJ56.SGD","IE0009355771.USD","LU2237438978.USD","IE00B894F039.SGD","SG9999001176.SGD","BBH","LU2089984988.USD","LU0432979614.USD","IBB","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0417517546.SGD","LU1093756325.SGD","GNMX","IE00BFTCPJ56.SGD","LU2362540622.SGD","LU0256863811.USD","IE00B19Z9Z06.USD","IE0009354923.USD","LU2362541273.HKD","GKOS","PBE","BIB","LU0058720904.USD","BK4548","LU1878469433.USD","SG9999001176.USD","BK4082","LU0061475181.USD","LU2236285917.USD","IBBQ","LU0432979614.USD","BK4532","IE00B4R5TH58.HKD","IE00BZ9MQY76.HKD","BK4588","IE00BJT1NW94.SGD","SG9999013999.USD","IE0002270589.USD","IE0009355771.USD","LU1674673691.USD","LU1035775433.USD","BK4585","IDNA","LU1585245621.USD","IE00B19Z3B42.SGD","LU0823416689.USD","LU1430594728.SGD","LU2417539215.USD","LU1069344957.HKD","LU2324357040.USD","IE00B2B36J28.USD","IE00B19Z3581.USD","LU2237438978.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","BK4567","LU1093756168.USD","BBH","LU1674673428.USD","IE0002141913.USD","LU2065731478.USD","TBXU","LU1778281490.HKD","LU0234570918.USD","IE00B894F039.SGD","LU0289739699.SGD","LU0320765992.SGD","BK4533","LU2456880835.USD","IE00B19Z9P08.USD","LU2362541513.USD","LU2462157665.USD","IBB","VRTX","SG9999001176.SGD","LU2089984988.USD","LU0889565916.HKD","LU0079474960.USD","BK4139","SGXZ57979304.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU1571399168.USD","LU0122379950.USD","IE00BZ08YR35.GBP","IE00BJT1NW94.SGD","BK4581","LU2242646821.SGD","AMGN","LU0109394709.USD","IE0009355771.USD","LU2089984988.USD","BK4533","IE00BJJMRZ35.SGD","LU1023059063.AUD","PJP","BK4585","IBB","IE0002141913.USD","BBH","01177","LU0058720904.USD","IBBQ","LU0289739699.SGD","LU1057294990.SGD","LU0889565916.HKD","LU2242652126.USD","BK4139","IE00BFTCPJ56.SGD","LU2112291526.USD","SG9999001440.SGD","LU1983299246.USD","BK4588","BK1589","HK0000165453.HKD","LU0320765992.SGD","TBXU","LU1061106388.HKD","IE00B4R5TH58.HKD","BK4599","LU2468319806.SGD","LU0868494617.USD","BK1191","IE00B2B36J28.USD","IE00BZ08YS42.EUR","BIB","PBE","BK1521","BK4566","BK1515","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0566484027.USD","IE0002270589.USD","LU2468319806.SGD","IE00BJT1NW94.SGD","PBE","SGXZ57979304.SGD","GNMX","IE00BJJMRZ35.SGD","VERX","LU2237438978.USD","LU2362541513.USD","BIB","BK4533","TBXU","IE00B4R5TH58.HKD","LU0058720904.USD","LU0289739699.SGD","LU2089984988.USD","BK4532","IE00BFTCPJ56.SGD","LU2456880835.USD","LU1815336091.USD","BK4023","LU0320765992.SGD","IE00BZ9MQY76.HKD","BK4585","LU1778281490.HKD","SG9999001176.SGD","IBB","BBH","IDNA","SG9999013999.USD","LU0256863811.USD","SG9999001176.USD","LU0234570918.USD","LU0889565916.HKD","LU1035775433.USD","LU0061475181.USD","BK4588","VRTX","IE00B19Z3581.USD","LU1093756325.SGD","LU2236285917.USD","IE00B19Z9Z06.USD","IE0002141913.USD","IE00B19Z9P08.USD","LU2462157665.USD","IE0009355771.USD","IBBQ","LU1093756168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660282476","title":"Press Release: Vertex Resource Group Ltd. Reports Second Quarter 2026 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660282476","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660282476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 06:31","pubTimestamp":1787178660,"startTime":"0","endTime":"0","summary":"Profit margin %                           28 %       24 %      26 %      23 %. Adjusted EBITDA %                         18 %       13 %      15 %      11 %.   See \"Non-IFRS Financial Measures\"HIGHLIGHTS FOR THE THREE MONTHS ENDED JUNE 30, 2026-- Net revenue increased $1.0 million over prior period while G&A expenses. -- Profit margin improved to 28.4% of net revenue, up from 24.3% in 2025.-- Adjusted EBITDA increased by $2.8 million, or 43.8%, compared to 2025,with Adjusted EBITDA growth in both the Environmental Consulting and. -- Returned to profitability with net income of $1.0 million, representing a. -- Free cash flow increased to $4.6 million from $1.3 million in Q2 2025.HIGHLIGHTS FOR THE SIX MONTHS ENDED JUNE 30, 2026-- Environmental Consulting net revenue increased by 7.8% compared to H1. -- G&A expenses were reduced by 6.5% compared to H1 2025.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0889565916.HKD","SPHQ","GNMX","IE0009355771.USD","LU0109394709.USD","BIB","LU2456880835.USD","IBB","BK4139","LU2462157665.USD","SG9999013999.USD","LU1674673691.USD","IE00B4R5TH58.HKD","LU0823416689.USD","LU0417517546.SGD","BK4533","LU1674673428.USD","LU0320765992.SGD","IBBQ","IE00B2B36J28.USD","LU1815336091.USD","SG9999001176.SGD","IE00B19Z3581.USD","BK4588","LU0079474960.USD","LU0757428866.USD","IE00B19Z9Z06.USD","LU2468319806.SGD","IE0002141913.USD","LU0061475181.USD","LU1069344957.HKD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","IDNA","PBE","SG9999001176.USD","LU0058720904.USD","BBH","LU0256863811.USD","IE00B19Z9P08.USD","LU0566484027.USD","VRTX","LU0432979614.USD","IE00B894F039.SGD","TBXU","LU1035775433.USD","IE00BJT1NW94.SGD","LU2089984988.USD","VERX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660737004","title":"Crinetics Faces Shareholder Challenges to Vertex Merger Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2660737004","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660737004?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171563,"startTime":"0","endTime":"0","summary":"An update from Crinetics Pharmaceuticals ( ($CRNX) ) is now available. On July 6, 2026, Crinetics agreed to be acquired by Vertex Pharmaceuticals v...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/crinetics-faces-shareholder-challenges-to-vertex-merger-deal?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2417539215.USD","LU2456880835.USD","LU1069344957.HKD","VRTX","IBB","LU2089984988.USD","BIB","LU0234570918.USD","LU1815336091.USD","LU2462157665.USD","IE00B19Z9Z06.USD","IE00B2B36J28.USD","VERX","IE00B19Z3581.USD","IE00B19Z9P08.USD","BK4533","SGXZ57979304.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","BBH","IBBQ","BK4585","SG9999013999.USD","LU1585245621.USD","LU1035775433.USD","IE00B4R5TH58.HKD","LU1778281490.HKD","GNMX","LU0320765992.SGD","SG9999001176.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU2324357040.USD","SG9999001176.USD","LU1093756168.USD","PBE","IDNA","TBXU","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU1674673691.USD","LU0256863811.USD","BK4567","BK4139","LU2362541513.USD","LU0566484027.USD","LU0432979614.USD","BK4588","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473115","title":"Moderna Inc. Stock Rallies 177.0%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473115","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660473115?lang=en_us&edition=fundamental","pubTime":"2026-08-20 04:32","pubTimestamp":1787171520,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. sailed 177.0% to $174.38 on what proved to be an all-around positive trading session for the stock market, with the NASDAQ Composite Index rising 0.2% to 26,331.09 and the Dow Jones Industrial Average rising 0.2% to 53,463.05.Moderna Inc. hit a new 52-week high, surpassing its previous peak of $85.60, which the company achieved on July 6th.The stock outperformed some of its peers, as Johnson & Johnson rose 0.8% to $273.41, Pfizer Inc. rose 3.6% to $28.24, and Gilead Sciences Inc. rose 2.90% to $147.60.Trading volume totaled 187.3 million, compared to the 50-day average of 7.3 million.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","LU0861579265.USD","LU1585245621.USD","LU1934455277.USD","IBBQ","LU1934455863.HKD","IE00BZ1G4Q59.USD","LU0122379950.USD","LU0234570918.USD","IE00B19Z3581.USD","IE00BSNM7G36.USD","LU2324357040.USD","TBXU","MRNA","BMED","MEDI","IE00B19Z3B42.SGD","MRNX","GNOM","LU0965509101.SGD","LU1430594728.SGD","LU0965509283.SGD","MRNY","IE00B7SZLL34.SGD","BK4139","SG9999015978.USD","LU0965508806.USD","LU0289739699.SGD","TMED","IE00BKVL7J92.USD","BK4578","LU1674673428.USD","LU0320765992.SGD","LU0889565916.HKD","BIB","IE0002270589.USD","BK4588","WDNA","LU0965509010.AUD","LU1778281490.HKD","BK4548","LGHT","BK4533","IDNA","BK4583","LU1571399168.USD","BBH","GILD","IBB","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}